Lexagene Holdings Inc LXXGQ

Healthcare Medical Devices

Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.

GREY:LXXGQ - Post by User

Lexagene Holdings Inc

<< Previous

Bullboard Posts

Next >>

Post by TanzaniteMotherLodeon Sep 15, 2021 9:50am

84 Views

Post# 33860984

Attending vet conference Sept 23-26th

Rounding out the month, LexaGene will travel to San Antonio for the Southwest Veterinary Symposium being held September 23-26. This four-day symposium is packed with continuing education, exhibits, and interactive labs. LexaGene will showcase its MiQLab to one of the largest regional veterinary audiences and will have a podium opportunity. Dr. Manoj Nair, MVSc, PhD, LexaGene’s Director of Applications and Assay Development, will speak on the topic of bringing automated PCR testing for pathogens inside the veterinary hospital.

https://ca.finance.yahoo.com/news/lexagene-miqlab-system-featured-three-114500638.html

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages